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Abstract
CRISPR-Cas adaptive immune systems are found in bacteria and archaea and provide defence against phage by inserting
phage-derived sequences into CRISPR loci on the host genome to provide sequence specific immunological memory against
re-infection. Under laboratory conditions the bacterium Pseudomonas aeruginosa readily evolves the high levels of
CRISPR-based immunity against clonal populations of its phage DMS3vir, which in turn causes rapid extinction of the
phage. However, in nature phage populations are likely to be more genetically diverse, which could theoretically impact the
frequency at which CRISPR-based immunity evolves which in turn can alter phage persistence over time. Here we
experimentally test these ideas and found that a smaller proportion of infected bacterial populations evolved CRISPR-based
immunity against more genetically diverse phage populations, with the majority of the population evolving a sm preventing
phage adsorption and providing generalised defence against a broader range of phage genotypes. However, those cells that
do evolve CRISPR-based immunity in response to infection with more genetically diverse phage acquire greater numbers of
CRISPR memory sequences in order to resist a wider range of phage genotypes. Despite differences in bacterial resistance
evolution, the rates of phage extinction were similar in the context of clonal and diverse phage infections suggesting
selection for CRISPR-based immunity or sm-based resistance plays a relatively minor role in the ecological dynamics in this
study. Collectively, these data help to understand the drivers of CRISPR-based immunity and their consequences for
bacteria-phage coexistence, and, more broadly, when generalised defences will be favoured over more specific defences.
Introduction
Bacterial and archaeal viruses can influence microbial
communities both through direct interactions with their
hosts as well as indirect effects on non-host populations
[1–4]. The selective pressure of viral predation has resulted
in the evolution of a range of archaeal and bacterial defence
mechanisms, which includes CRISPR-Cas (clustered
regularly interspaced short palindromic repeats; CRISPR-
associated) systems, prokaryotic argonautes, restriction–
modification (R–M) systems, surface modification (sm),
toxin–antitoxin and abortive infection systems [5]. These
defences differ in multiple ways including the range of
phage to which they provide resistance (generalist versus
specialist) and in their fitness costs [6]. In bacteria two of
these mechanisms, sm and CRISPR-Cas systems, are often
found to be important for rapid evolution of phage resis-
tance, with sm perhaps representing the simplest, and the
most common, line of defence by mutation of the bacterial
cell surface, obscuring or altering the receptor that is used
by the phage to attach to the cell [7]. Alternatively, bacteria
may employ their CRISPR-Cas adaptive immune systems,
which occur in ~30% of the bacterial genomes sequenced to
date [8]. Initially naive bacteria acquire CRISPR-based
immunity by incorporating nucleic acids from phage gen-
omes into CRISPR loci on their own genome [9, 10], where
they are known as “spacers” [11]. Processed CRISPR
transcripts guide Cas proteins to detect and destroy re-
infecting phage that carry the cognate target sequence
[12, 13]. Phage can in turn overcome CRISPR-based
immunity by acquiring a point mutation in the target
sequence on their genome [14], although the emergence and
spread of such phage “escape” mutants is constrained by
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both the diversity of CRISPR immunity alleles in the bac-
terial population and the fitness costs associated with the
phage mutations [15–18].
While our mechanistic understanding of the different
defence strategies of bacteria has raced ahead, the ecolo-
gical conditions that favour one type of defence over
another, and their consequences for the ensuing bacteria-
phage population dynamics remain unclear [6, 19]. Previous
work has shown that the inducible cost of CRISPR-Cas
means CRISPR-based immunity will typically be favoured
over more costly constitutive defences, such as sm, under
relatively low forces of infection [20]. However, because
the cost of sm-based resistance is fixed, it may provide a
selective advantage when the force of infection is high.
Given that the cost of sm-based resistance can increase in
the presence of bacterial competitors, CRISPR-based
immunity evolution may generally be more important in a
microbial community context [21].
Here, we focus on another key distinction between the
different types of defence: their different levels of specificity.
CRISPR-Cas mediated defence is necessarily fairly specific,
with a single spacer unlikely to be able to target all phage
genotypes within a population. While spacer diversity within
bacterial populations provides an additional population level
resistance by increasing the chance of phage extinction, this
benefit may be reduced if phage populations are sufficiently
diverse and hence there are variants that can escape targeting
by many spacers. By contrast, sm-based resistance provides
resistance against a broad range of phage genotypes, and
typically requires multiple mutations for phage to be over-
come [22–24]. We therefore hypothesised that increasing the
diversity of infecting phage populations would increase
selection for sm-based resistance.
Here we test the effect of phage genetic diversity using
P. aeruginosa PA14 and its phage DMS3vir. P. aerugi-
nosa is an opportunistic human pathogen and a model
organism for studying the mechanism and evolutionary
ecology of CRISPR-Cas systems. P. aeruginosa PA14 can
evolve resistance to the phage DMS3vir through either sm
or CRISPR-Cas [20, 25]. In order to directly test the
impact of phage genetic diversity on the frequency at
which CRISPR-based immunity evolves, we generated
phage DMS3vir populations with increased genetic diver-
sity by serial passage of the phage on a phage-sensitive P.
aeruginosa PA14 derived strain. We then exposed the
bacterium P. aeruginosa strain PA14 to the genetically
more diverse populations of the phage DMS3vir, or to a
clonal phage DMS3vir population. Following infection
with genetically diverse phage populations, a smaller
proportion of the initially phage-sensitive bacterial popu-
lations relied on CRISPR-based immunity. Moreover,
those bacteria that relied on CRISPR-based immunity in
the face of diverse phage populations acquired more
spacers per individual compared with those that were
exposed to clonal phage populations, presumably because
this allows them to resist a wider range of phage genotypes
[16, 26]. The ultimate effect of the frequency of CRISPR-
based immunity on the rate of phage extinction was
however independent of the levels of standing genetic
variation in the phage populations.
Methods
Bacterial strains and phages
P. aeruginosa UCBPP-PA14 (referred to as WT, carrying no
spacers with a perfect match to the DMS3vir genome), P.
aeruginosa UCBPP-PA14 csy3::LacZ [25] (referred to as
CRISPR-KO, since it carries a disruption of an essential cas
gene that causes the CRISPR-Cas system to be non-func-
tional), and P. aeruginosa UCBPP-PA14 mutS::MAR2xT7
[27], which was kindly provided by Alexandro Rodriguez
Rojas (below this strain is also referred to as a mutator strain
of PA14), and the CRISPR-KO-derived sm (described pre-
viously in ref. [20]), were used in all experiments. The obli-
gately lytic phage DMS3vir was used in all experiments, and
has previously been described in Cady et al. [25]. All statis-
tical analyses were carried out in R version 3.4.4.
Generating diversity within phage populations
To generate genetically diverse populations of phage
DMS3vir, the phage was amplified on P. aeruginosa
UCBPP-PA14 mutS::MAR2xT7, a transposon mutant of P.
aeruginosa that lacks the mutS gene. No DNA-polymerase
has been characterised on the DMS3vir genome so we
hypothesised that replication on a mutator strain of its host
would result in increased levels of genetic variation within
the phage population. Bacteria and phage were grown in
10 ml LB media, by inoculating 1:100 from an overnight
culture of P. aeruginosa UCBPP-PA14 mutS::MAR2xT7
and subsequent infection with 106 pfu (plaque forming
units) of DMS3vir. Twelve independent cultures were
inoculated, followed by incubation at 37 °C while shaking
at 180 rpm. After 24 h phages were sampled via chloroform
extraction by mixing the overnight cultures 2:1 with
chloroform followed by vortexing and centrifugation at
3500 rpm to pellet bacterial debris. Supernatant containing
phage was stored at 4 °C and used to infect naive P. aer-
uginosa UCBPP-PA14 mutS::MAR2xT7 cells in fresh
media, as described above. This procedure was repeated
daily for 17 days, resulting in phage populations with
increased levels of genetic diversity. We then generated
derived clonal populations by isolating a single phage clone
from each of the twelve diverse populations, using double
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plaque purification, followed by a single round of amplifi-
cation on P. aeruginosa UCBPP-PA14 csy3::LacZ bacteria.
Deep sequencing of phage populations
To measure the levels of standing genetic variation in the
diverse and derived clonal phage populations that were gen-
erated as described above, we extracted phage DNA from
~108–109 pfu using the Norgen phage DNA isolation kit, fol-
lowing the manufacturer’s instructions. After QC with Nano-
drop, Qubit and electrophoresis to quantify the amount and
quality of extracted material, the extracted DNAwas sequenced
using MiSeq by the Liverpool Center for Genomic Research,
using previously described protocols [16]. Ancestral virus was
processed in parallel as a control for SNP calling. Barcoded
Illumina Truseq Nano libraries were constructed from each
DNA sample with an ~350 base insert size and 2 × 250 base
reads generated on an Illumina MiSeq platform. Reads were
trimmed for the presence of Illumina adaptor sequences using
Cutadapt version 1.2.1 and Sickle version 1.200 with a mini-
mum window quality score of 20. After trimming most reads
were around 250 bases and reads shorter than 10 bases were
removed. Overlapping reads were joined using Flash version
1.2.8 to create high quality sequence at ~8000× coverage of
DMS3vir per sample. Reads from evolved phage populations
were mapped to the ancestral DMS3vir genomes using bwa
mem version 0.7.12. Sites which had coverage lower than 100
and an alternate allele frequency of >0.005 in the ancestor were
filtered out to minimise sequencing error and noise. Data for
SNPs which were fixed (>0.95 frequency) in any of the clonal
population samples was extracted. No fixed mutations were
found in the diverse populations that were not present in one of
the clonal populations. Sequence data have been deposited in
the European Nucleotide Archive under accession number
ENA: PRJEB31472
Infectivity of genetically diverse phage on CRISPR-
resistant bacteria
We investigated the effect of phage genetic diversity on the
ability of the phage population to overcome CRISPR target-
ing by testing the 12 experimentally evolved phage popula-
tions for infectivity against 12 CRISPR-immune bacteria. The
bacteria used for infectivity tests were obtained from previous
co-evolution experiments with DMS3vir. The selected iso-
lates have been sequenced to ensure each was carrying a
unique single spacer sequence [16]. The infectivity of phage
was determined by spot assay on a lawn of each of the
CRISPR-immune bacteria and the CRISPR-KO strain (which
carries an inactive CRISPR-Cas system and is therefore
sensitive to phage infection). Infectivity is expressed as the
efficiency of plaquing (EOP) on the CRISPR-immune host,
which was calculated by dividing the pfu/ml formed by the
phage population on the relevant CRISPR-immune bacteria
by the pfu/ml formed on the CRISPR-KO strain. In addition,
we tested all phage populations’ infectivity against 6
CRISPR-immune bacterial strains each carrying two spacers,
and against one strain with sm-based resistance.
Measuring the effect of diversity on phage
persistence
To investigate how genetic diversity within a phage popu-
lation affects the phage population dynamics we inoculated
6 ml M9 media supplemented with 0.2% glucose 1:100 with
WT cells and added 104 pfu of either clonal or diverse
phage. Phage titres were measured after 1, 3 and 5 days:
Phages were extracted using chloroform as described above
and a dilution series was spotted on a lawn of soft LB (0.5%
agar) inoculated with P. aeruginosa PA14 csy3::LacZ to
quantify phage titres.
Effect of phage diversity on CRISPR-based immunity
evolution
To investigate how the diversity of an infecting phage
population affects the evolution of resistance mechanisms
in the host we co-cultured WT P. aeruginosa UCBPP-
PA14 with either clonal or diverse phage for 3 days. Glass
vials were filled with 6 ml of M9 media supplemented with
0.2% glucose and inoculated with 106 cfu/ml of P. aeru-
ginosa and 104 pfu of phage from one of either the diverse
or clonal populations (n= 8) then incubated for 24 h (±3 h)
at 37 °C while shaking at 180 rpm. Transfers to fresh media
were performed daily at a concentration of 1:100. The
bacterial populations were sampled at 3 dpi (days post
infection) and resistance profiles of the bacterial isolates
from the experimental populations were determined via
streak assays against either ancestral phage (DMS3vir) or
the isogenic phage DMS3vir-AcrIF1, which carries an
antiCRISPR (Acr) gene that blocks the CRISPR-Cas sys-
tem of P. aeruginosa UCBPP-PA14 [28]. Lines of phage
were applied to agar plates and allowed to dry for 20 min.
Bacterial colonies were streaked across the lines of phage
and plates were incubated overnight at 37 °C. Bacteria were
scored to be CRISPR immune when they were resistant to
DMS3vir, but not to DMS3vir-AcrIF1 (also associated with
a motile, swarming phenotype) and surface-based resis-
tance was scored when they were resistant to both phages
(also associated with a smooth, non-motile phenotype).
Bacteria were scored to be sensitive when they displayed
resistance to neither phage. In addition, evolution of
CRISPR-based immunity was further confirmed by PCR
of both CRISPR loci, using primer pairs 5′-CTAAGCC
TTGTACGAAGTCTC-3′ and 5′-CGCCGAAGGCCAGC
GCGCCGGTG-3′ to determine spacer acquisition at the
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CRISPR 1 locus, and primer pairs 5′-GCCGTCCAGAA
GTCACCACCCG-3′ and 5′-TCAGCAAGTTACGAGAC
CTCG-3′ to determine spacer acquisition at the CRISPR
2 locus.
Results
Diverse phage populations harbour more SNPs
Given the sequence specificity of CRISPR-based immunity
against phage, we hypothesised that the phage genetic
diversity will constrain the evolution of CRISPR-based
immunity relative to sm-based resistance, with potential
knock-on effects for phage persistence. To test this, we
amplified phage DMS3vir on a mutator strain of P. aeru-
ginosa PA14 with the aim of increasing phage genetic
diversity. After 17 passages of DMS3vir on the mutator
strain, we performed deep sequencing analysis on the phage
populations to examine if the standing levels of genetic
diversity (i.e. SNPs frequency) were increased relative to
paired clonal control populations that were derived from
each of the diverse populations.
Although the sensitivity of deep sequencing is insufficient
to identify rare genotypes, it revealed 40 SNPs across the 16
phage populations (eight “clonal” and eight “diverse”) which
were present at 0.01% frequency or higher after processing to
remove sequencing noise and error. All of the SNPs found in
clonal populations were also present in the paired diverse
population. Based on this analysis, diverse populations were
found to contain an average of 9.2 SNPs (ranging from 5–13
in each population), while clonal populations were found to
only have an average of three SNPs (ranging from 1–4).
However, SNP frequencies based on deep-sequencing analy-
sis inevitably underestimate the true level of genetic variation
in the populations as rare alleles are filtered out to limit the
noise from sequencing errors. Nonetheless, a Kruskal–Wallis
test confirmed that the diversified phage populations had a
higher average SNP frequency than the paired clonal strains
(Fig. 1a) (χ2(2)= 11.94, p < 0.001), and most SNPs were
located close to gene 42, which contains a CRISPR priming
site [20], which suggests that the observed SNP clustering
may result from acquisition of spacers from this area of the
phage genome and subsequent evolution of escape by the
phage during the passaging on the mutator strain.
Genetically diverse phage are more infective on
hosts with CRISPR-based immunity
Previous work has shown that point mutations in the phage
genome sequence that is targeted by the CRISPR-Cas
immune system often allows the phage to by-pass this
defence [14, 16, 29, 30]. We therefore predicted that the
genetically more diverse phage populations would have
greater infectivity on bacteria with CRISPR-based immu-
nity compared with their paired clonal phage populations or
the ancestral population. Given that it is much harder for
phage to evolve to recognise a novel receptor [24], we
expected that the levels of infectivity of the diversified and
clonal phage populations would be the same on a bacterium
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Fig. 1 The 12 evolved phage populations harbour greater genetic
variation than the derived clonal populations. a The frequency of
SNPs in diverse (purple) phage populations (N= 12) and clonal (blue)
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clonal phage populations on each of 12 CRISPR-resistant bacter-
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spacer targeting the ancestral phage. Infectivity of phage populations
was also tested against six BIMs carrying two spacers targeting the
ancestral phage (these data are shown as one bar as no escape mutants
were identified against any of the six clones possessing two spacers
each) and a surface mutant (sm). All graphs show averages and error
bars represent 95% confidence intervals.
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with sm-based resistance. To test these ideas, we examined
the levels of infectivity for each of our diversified and clonal
populations against 12 clones with CRISPR-based immu-
nity of P. aeruginosa PA14, each possessing a single
unique spacer, and against six clones with CRISPR-based
immunity each carrying two spacers targeting DMS3vir,
which is harder to overcome by point mutation [16, 26], as
well as a PA14 strain with sm-based resistance. As expec-
ted, we found that infectivity of genetically more diverse
phage populations was higher on bacteria with CRISPR-
based immunity than that of clonal phage populations
(Wilcoxon signed rank test, W= 1359, Z=−9.5082, p <
0.0001), but neither of the phage populations were infective
against hosts with two spacers or sm-based resistance
(Fig. 1b). Consistent with the idea that SNPs are present at a
low frequency in the phage population, the EOP of more
genetically diverse phage was typically around 10−5 for
each spacer tested, an increase of around 10–200 fold
compared with the clonal phage populations. Collectively,
these data support the idea that phage diversified during the
repeated amplification on the mutator strain, resulting in
greater infectivity on CRISPR-resistant bacteria.
Type of evolved host resistance depends on the
levels of phage genetic diversity
In order to study if and how phage genetic diversity impacts the
frequencies of CRISPR and sm-based resistance that evolve in
the bacterial population following infection, we performed an
evolution experiment and monitored the phage population
dynamics as well as the levels of CRISPR-based immunity
observed following infection of WT PA14 with the clonal or
more genetically diverse phage DMS3vir populations. Con-
sistent with previous studies [16, 20], we found that phage titres
increased in all replicates following infection of the WT strain,
which is expected given that bacteria are initially sensitive to
the phage. However, from 1 dpi onwards, phage titres started to
decline until complete extinction at 6 dpi, with no clear dif-
ference between the diversified and paired clonal phage
populations (Fig. 2a, ANOVA, F(1,22)= 0.02, p > 0.8).
However, analysis of individual bacterial clones that were
isolated at 3 dpi revealed clear differences in the frequencies of
CRISPR-based immunity and sm-based resistance that had
evolved following infection with genetically diverse or clonal
phage populations (Fig. 2b, ANOVA, F(2,1)= 54.72, p <
0.0001). Specifically, we found that the frequency of sm-based
resistance was higher in populations challenged with a
genetically more diverse phage population than in populations
challenged with the paired clonal population (Post hoc analysis
with Tukey HSD, p < 0.0001), and this was associated with a
corresponding decrease in the frequency of CRISPR-based
immunity (p < 0.0001) (Fig. 2b). These data therefore show
that increasing phage genetic diversity can cause a decrease in
the frequency at which CRISPR-based immunity evolves and a
corresponding increase in the frequency at which sm-based
resistance evolves.
Bacteria evolving CRISPR-based immunity against
genetically diverse phage carry more spacers
Given that the number of spacers targeting a phage within a
single host influences the propensity of phage to overcome
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CRISPR-based immunity (Fig. 1b and [16, 26]), we also
examined how genetic diversity within infecting phage
populations affects the number of spacers that individual
bacterial clones acquire. PCR analysis of the CRISPR loci
of bacterial clones following exposure to either the geneti-
cally more diverse phage DMS3vir populations or the
paired clonal controls revealed that the patterns of spacer
acquisition in cells using CRISPR-based immunity differed
depending on the genetic diversity of the phage they were
infected with (Fig. 3b). Specifically, upon infection with
clonal phage the majority of cells which had acquired
CRISPR-based immunity had acquired only one spacer
(Fig. 3a, Tukey HSD, p < 0.005), whereas upon infection
with genetically more diverse phage the majority of cells
which had acquired CRISPR-based immunity had acquired
multiple spacers (Tukey HSD, p < 0.05). Despite differ-
ences in the patterns of spacer acquisition, analysis with
ANOVA revealed the average total number of spacers per
clone gained was not affected (F(1,14)= 7.42, p > 0.1)
(Fig. 2c). Collectively, the higher proportion of bacteria
with sm-based resistance or CRISPR-based immunity with
multiple new spacers in response to infection with geneti-
cally more diverse phage suggests selection for more gen-
eralist defence mechanisms under those conditions.
Discussion
Here, we tested whether increasing genetic diversity within
a parasite population will increase selection for generalist
over specific immune defences. We find that infecting P.
aeruginosa with experimentally evolved populations of
phage DMS3vir that have elevated levels of standing
genetic diversity results in, first, higher frequencies of sm-
based resistance compared with CRISPR-based immunity
and that, second, cells with CRISPR-based immunity are
more likely to acquire multiple spacers. Interestingly no
difference in phage persistence between populations that
were infected with clonal or genetically more diverse phage
populations were observed. These data show that genetic
diversity has an important effect on the frequencies of
CRISPR-based immunity (specialist defence) and sm-based
resistance (generalist defence) in this system. While the
elevated genetic variation of phage DMS3vir is presumably
more reflective of natural environments compared with the
clonal phage populations that are typically used in experi-
mental evolution studies, it should be noted that our
experiments do not capture the complexity of natural
environments where different phages with overlapping host
ranges tend to coexist, which can further impact the evo-
lution of CRISPR-based immunity [31].
CRISPR-Cas is a specific and adaptive immune defence
that is widespread, yet not equally abundant in different
ecosystems. Although CRISPR-Cas systems are found in a
diverse range of habitats, there is a highly uneven dis-
tribution across different environments. Metagenomic
sequence analyses have shown that the frequency of the
evolution and maintenance of CRISPR-Cas systems in
bacterial and archaeal communities may be linked to
environmental factors as higher frequencies of CRISPR-Cas
are often found in extreme environments [18]. This suggests
that there are environmental attributes that constrain the
fitness advantages (or ecological success) of this form of
phage defence. Some of the earliest studies that looked at
the ecological distributions of CRISPR-Cas immune sys-
tems observed that these systems are overrepresented in
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high-temperature environments, with thermophiles typically
possessing more and longer CRISPR arrays [32, 33].
Indeed, over 90% of hyperthermophilic archaea harbour
CRISPR-Cas, and these environments are generally
throught to be associated with moderate virus diversity [34].
The ancestral primitive CRISPR-Cas systems likely evolved
in archaea and were subsequently acquired by bacteria
through horizontal transfer [35]. It has been suggested that
the prevalence of CRISPR-Cas in hyperthermophilic con-
ditions may be due to the lower mutation rates in those
environments, which is supported by correlational and
theoretical studies [32, 36–39]. However, apart from
accelerating the evolution of “escape” phage, high mutation
rates will also increase the rate at which sm-based resistance
evolves in the bacterial population, hence reducing the
relative benefit of CRISPR-Cas immune systems [40]. Here
we teased these two effects apart by exposing bacterial
populations to experimentally diversified or clonal phage
populations of the phage DMS3vir. Our experimental data
support the idea that phage genetic diversity can tip the
balance in the evolution of different defence strategies that
bacteria employ to combat phage infections. Given that
CRISPR-Cas immune systems are highly sensitive to the
evolution of “escape” phage that overcome CRISPR
immunity through mutation of their target sequences,
greater levels of phage genetic diversity are likely to favour
generalist defences that are more robust to phage evolution.
Indeed, our experiments show that in this empirical system
phage was unable to overcome sm-based resistance. Evo-
lution of a novel receptor specificity would presumably
require multiple adaptations in the phage tail fibres [24], and
while this will occur in certain environments, the rate at
which this happens will in most cases be low relative to the
rate of CRISPR escape mutation.
The results of this study highlight how ecological vari-
ables can drive the evolution of bacterial defence strategies
and it will likely be important to consider phage genetic
diversity when studying natural systems. For example, we
may expect to find higher levels of viral genetic diversity,
and therefore lower levels of CRISPR-based immunity, in
well-mixed environments such as in aquatic ecosystems, but
the opposite may be true in systems with less migration, and
therefore lower viral diversity, such as in soil. Environments
associated with low viral mutation rates, as is often found in
thermophilic microbial communities, will likely harbour
higher levels of CRISPR-based immunity as generalist
defences with a constitutive cost such as sm will have a
selective disadvantage under these conditions. Biotic com-
plexity is frequently ignored in laboratory evolution studies.
It is also important to consider that in bacteria-phage
interactions in natural ecosystems there will usually be a
range of different phage types able to infect each host, and
further work is needed to clarify how the presence of
multiple phage would affect the evolution of bacterial
resistance.
Here we have shown that diversity in an infecting
parasite population can impact the outcome of host-parasite
interactions. In the data presented here our experimentally
evolved phages were passaged on a mutant genotype of the
same host used in our experiments. Therefore, the mutations
acquired may not be as varied as when phage evolves on a
range of hosts as will typically be the case in nature. The
observed effects of intraspecific diversity (i.e. genetic
diversity within the same species of phage) have been
previously predicted by studies that modelled CRISPR-
phage interactions [36], but as far as we are aware this is the
first work to demonstrate this experimentally. This work
further contributes to our understanding of the role of the
CRISPR-Cas adaptive immune system in a microbial
community context, and complements previous work on the
role of bacterial diversity [21]. Furthermore, this study
suggests that genetic diversity is an important driver of
when specific defences are favoured over generalist defen-
ces and should therefore be considered when investigating
any host-parasite interaction where generalist or specific
defences can evolve.
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